NASDAQ:CLBS
Delisted
Caladrius Biosciences Stock News
$3.55
+0.0399 (+1.14%)
At Close: Jan 27, 2023
The Keys to Successfully Timing the Markets - February 14, 2020
02:22pm, Friday, 14'th Feb 2020
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
eSight Corporation Announces New President and CEO
02:00pm, Wednesday, 12'th Feb 2020
TORONTO, Feb. 12, 2020 (GLOBE NEWSWIRE) -- eSight Corporation, a leading vision enhancing platform, is pleased to announce the appointment of Robert Vaters as President and CEO effective February 3r
Edited Transcript of BDX earnings conference call or presentation 6-Feb-20 1:00pm GMT
02:58am, Friday, 07'th Feb 2020
Q1 2020 Becton Dickinson and Co Earnings Call
Becton, Dickinson (BDX) Q1 Earnings Beat, Revenues Rise Y/Y
02:24pm, Thursday, 06'th Feb 2020
Becton, Dickinson (BDX) sees softness in BD Medical unit, slashes FY20 view.
Caladrius Biosciences to Participate at Upcoming February Conferences
01:30pm, Monday, 03'rd Feb 2020
BASKING RIDGE, N.J., Feb. 03, 2020 -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company.
The Market Timing Secrets No One Talks About - January 27, 2020
02:17pm, Monday, 27'th Jan 2020
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Market Timing Secrets No One Talks About - January 27, 2020
02:17pm, Monday, 27'th Jan 2020
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
20 Biopharma Stocks for Huge Upside Potential in 2020
12:05pm, Saturday, 11'th Jan 2020
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
